{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:38:38Z","timestamp":1793997518407,"version":"4.8.0"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014364","name":"National Children's Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.pharmthera.2020.107623","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T11:16:44Z","timestamp":1593688604000},"page":"107623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention"],"prefix":"10.1016","volume":"215","author":[{"given":"Stephanie","family":"Annett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-5793(94)01001-3","article-title":"Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506","volume":"352","author":"Ahern","year":"1994","journal-title":"FEBS Letters"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107623_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095992","article-title":"Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFN","volume":"9","author":"Akiyama","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12192-010-0248-0","article-title":"Versatile TPR domains accommodate different modes of target protein recognition and function","volume":"16","author":"Allan","year":"2011","journal-title":"Cell Stress & Chaperones"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0020","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: Mechanism, combinations, and clinical outcome","author":"Alsaab","year":"2017","journal-title":"Frontiers in Pharmacology. Frontiers Media S.A"},{"issue":"25","key":"10.1016\/j.pharmthera.2020.107623_bb0025","doi-asserted-by":"crossref","first-page":"20876","DOI":"10.1074\/jbc.M112.344929","article-title":"Increased resting intracellular calcium modulates NF-\u03baB-dependent inducible nitric-oxide synthase gene expression in dystrophic mdx skeletal myotubes","volume":"287","author":"Altamirano","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41416-019-0649-5","article-title":"FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer","volume":"122","author":"Annett","year":"2020","journal-title":"British Journal of Cancer"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107623_bb0035","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/cdd.2016.44","article-title":"The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51","volume":"23","author":"Antunica-Noguerol","year":"2016","journal-title":"Cell Death and Differentiation"},{"issue":"5852","key":"10.1016\/j.pharmthera.2020.107623_bb0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.1147379","article-title":"Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38","volume":"318","author":"Bai","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01783-y","article-title":"Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function","volume":"8","author":"Balsevich","year":"2017","journal-title":"Nature Communications"},{"issue":"24","key":"10.1016\/j.pharmthera.2020.107623_bb0050","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1007\/s00018-006-6215-3","article-title":"Immunophilins: For the love of proteins","volume":"63","author":"Barik","year":"2006","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040148","article-title":"Dual-family peptidylprolyl isomerases (immunophilins) of select monocellular organisms","author":"Barik","year":"2018","journal-title":"Biomolecules MDPI AG"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","author":"Barnes","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0065","doi-asserted-by":"crossref","DOI":"10.2217\/nnm.15.115","article-title":"RALA-mediated delivery of FKBPL nucleic acid therapeutics","author":"Bennett","year":"2015","journal-title":"Nanomedicine (London, England)"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107623_bb0070","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1172\/JCI69003","article-title":"Accelerated neurodegeneration through chaperone-mediated oligomerization of tau","volume":"123","author":"Blair","year":"2013","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cellsig.2017.06.013","article-title":"Diverse structures, functions and uses of FK506 binding proteins","volume":"38","author":"Bonner","year":"2017","journal-title":"Cellular Signalling"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ncb1086","article-title":"A physical and functional map of the human TNF-alpha\/NF-kappa B signal transduction pathway","volume":"6","author":"Bouwmeester","year":"2004","journal-title":"Nature Cell Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0092-8674(94)90214-3","article-title":"Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein","volume":"77","author":"Brillantes","year":"1994","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/endo-86-3-519","article-title":"Pituitary-adrenal function in the squirrel monkey","volume":"86","author":"Brown","year":"1970","journal-title":"Endocrinology"},{"issue":"6483","key":"10.1016\/j.pharmthera.2020.107623_bb0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin-receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nature Reviews Immunology"},{"issue":"44","key":"10.1016\/j.pharmthera.2020.107623_bb0105","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","article-title":"Structure of the bone morphogenetic protein receptor ALK2 and implications for Fibrodysplasia Ossificans Progressiva","volume":"287","author":"Chaikuad","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"51","key":"10.1016\/j.pharmthera.2020.107623_bb0110","doi-asserted-by":"crossref","first-page":"32923","DOI":"10.1074\/jbc.271.51.32923","article-title":"FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12: Prevention by the immunosuppressant drugs FK506 and rapamycin","volume":"271","author":"Chambraud","year":"1996","journal-title":"Journal of Biological Chemistry"},{"issue":"13","key":"10.1016\/j.pharmthera.2020.107623_bb0115","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1093\/emboj\/16.13.3866","article-title":"Mechanism of TGFbeta receptor inhibition by FKBP12","volume":"16","author":"Chen","year":"1997","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0120","article-title":"Copper transport protein Antioxidant-1 promotes inflammatory neovascularization via chaperone and transcription factor function","volume":"5","author":"Chen","year":"2015","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107623_bb0125","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ki.2012.104","article-title":"Endothelial cell transforming growth factor-\u03b2 receptor activation causes tacrolimus-induced renal arteriolar hyalinosis","volume":"82","author":"Chiasson","year":"2012","journal-title":"Kidney International"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10875-010-9463-9","article-title":"Dexamethasone-induced FKBP51 expression in peripheral blood mononuclear cells could play a role in predicting the response of asthmatics to treatment with corticosteroids","volume":"31","author":"Chun","year":"2011","journal-title":"Journal of Clinical Immunology"},{"issue":"19","key":"10.1016\/j.pharmthera.2020.107623_bb0135","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2017-04-780692","article-title":"The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes","volume":"130","author":"Colucci","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0140","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1073\/pnas.0610362104","article-title":"Childhood maltreatment predicts adult inflammation in a life-course study","volume":"104","author":"Danese","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"40","key":"10.1016\/j.pharmthera.2020.107623_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18632\/oncotarget.19309","article-title":"A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma","volume":"8","author":"D\u2019Arrigo","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-019-0216-0","article-title":"The splicing FK506-binding protein-51 isoform plays a role in glioblastoma resistance through programmed cell death ligand-1 expression regulation","volume":"5","author":"D\u2019Arrigo","year":"2019","journal-title":"Cell Death Discovery"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107623_bb0155","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1074\/jbc.C100531200","article-title":"A new first step in activation of steroid receptors: Hormone-induced switching of FKBP51 and FKBP52 immunophilins","volume":"277","author":"Davies","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","author":"Daynes","year":"2002","journal-title":"Nature Reviews. Immunology"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107623_bb0165","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1210\/en.2005-0027","article-title":"Structure-function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity","volume":"146","author":"Denny","year":"2005","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107623_bb0170","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/nar\/gky008","article-title":"The prolyl isomerase FKBP25 regulates microtubule polymerization impacting cell cycle progression and genomic stability","volume":"46","author":"Dilworth","year":"2018","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0175","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1165\/rcmb.2013-0222OC","article-title":"Dissociation of FK506-binding protein 12.6 kD from ryanodine receptor in bronchial smooth muscle cells in airway hyperresponsiveness in asthma","volume":"50","author":"Du","year":"2014","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107623_bb0180","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.molimm.2008.09.029","article-title":"IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes","volume":"46","author":"Dur\u00e9","year":"2009","journal-title":"Molecular Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0185","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1038\/celldisc.2016.2","article-title":"The interchange of immunophilins leads to parallel pathways and different intermediates in the assembly of Hsp90 glucocorticoid receptor complexes","volume":"2","author":"Ebong","year":"2016","journal-title":"Cell Discovery"},{"issue":"17","key":"10.1016\/j.pharmthera.2020.107623_bb0190","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1128\/MCB.00649-09","article-title":"Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin","volume":"29","author":"Echeverria","year":"2009","journal-title":"Molecular and Cellular Biology"},{"issue":"supplement 5","key":"10.1016\/j.pharmthera.2020.107623_bb0200","article-title":"383PA A phase I dose-escalation study of the novel peptide ALM201 in patients (pts) with advanced solid tumours","volume":"28","author":"El-Helali","year":"2017","journal-title":"Annals of Oncology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107623_bb0205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4155\/fmc.13.7","article-title":"Hsp90-binding immunophilins as a potential new platform for drug treatment","volume":"5","author":"Erlejman","year":"2013","journal-title":"Future Medicinal Chemistry"},{"issue":"38","key":"10.1016\/j.pharmthera.2020.107623_bb0210","doi-asserted-by":"crossref","first-page":"26263","DOI":"10.1074\/jbc.M114.582882","article-title":"NF-\u03baB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: A role for peptidyl-prolyl isomerase activity","volume":"289","author":"Erlejman","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0215","author":"EU Clinical Trials Register"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0220","series-title":"A Clinical guide to the treatment of the human stress response","first-page":"3","article-title":"The concept of stress","author":"Everly","year":"2019"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057508","article-title":"InterAKTions with FKBPs - mutational and pharmacological exploration","volume":"8","author":"Fabian","year":"2013","journal-title":"PLoS One"},{"issue":"5548","key":"10.1016\/j.pharmthera.2020.107623_bb0230","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations","volume":"193","author":"Fleischmann","year":"2016","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"18","key":"10.1016\/j.pharmthera.2020.107623_bb0240","doi-asserted-by":"crossref","first-page":"14884","DOI":"10.1074\/jbc.M010809200","article-title":"Evidence that the Peptidylprolyl isomerase domain of the hsp90-binding Immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus","volume":"276","author":"Galigniana","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"46","key":"10.1016\/j.pharmthera.2020.107623_bb0245","doi-asserted-by":"crossref","first-page":"13602","DOI":"10.1021\/bi020399z","article-title":"Binding of hsp90-associated Immunophilins to cytoplasmic dynein: Direct binding and in vivo evidence that the Peptidylprolyl isomerase domain is a dynein interaction domain \u2020","volume":"41","author":"Galigniana","year":"2002","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4161\/nucl.1.4.11743","article-title":"Role of molecular chaperones and TPR-domain proteins in the cytoplasmic transport of steroid receptors and their passage through the nuclear pore","volume":"1","author":"Galigniana","year":"2010","journal-title":"Nucleus"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12861-018-0167-3","article-title":"Comparative analysis of FKBP family protein: Evaluation, structure, and function in mammals and Drosophila melanogaster","volume":"18","author":"Ghartey-Kwansah","year":"2018","journal-title":"BMC Developmental Biology"},{"issue":"6244","key":"10.1016\/j.pharmthera.2020.107623_bb0260","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/341758a0","article-title":"A receptor for the immuno-suppressant FK506 is a cis\u2013trans peptidyl-prolyl isomerase","volume":"341","author":"Harding","year":"1989","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1874467208666150519113427","article-title":"Immunophilins: Structures, mechanisms and ligands","volume":"9","author":"Harikishore","year":"2015","journal-title":"Current Molecular Pharmacology"},{"issue":"17","key":"10.1016\/j.pharmthera.2020.107623_bb0270","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1021\/bi020073q","article-title":"All of the protein interactions that link steroid receptor\u00b7Hsp90\u00b7Immunophilin Heterocomplexes to cytoplasmic dynein are common to plant and animal cells \u2020","volume":"41","author":"Harrell","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2019.09.003","article-title":"Focus on FKBP51: A molecular link between stress and metabolic disorders","author":"H\u00e4usl","year":"2019","journal-title":"Molecular Metabolism Elsevier GmbH"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","article-title":"YY1 regulates cancer cell immune resistance by modulating PD-L1 expression","volume":"43","author":"Hays","year":"2019","journal-title":"Drug Resistance Updates"},{"issue":"44","key":"10.1016\/j.pharmthera.2020.107623_bb0285","doi-asserted-by":"crossref","first-page":"32311","DOI":"10.1074\/jbc.M705785200","article-title":"Signal responsiveness of I\u03baB kinases is determined by Cdc37-assisted transient interaction with Hsp90","volume":"282","author":"Hinz","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107623_bb0290","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1089\/omi.2018.0027","article-title":"Sarcoidosis related novel candidate genes identified by multi-omics integrative analyses","volume":"22","author":"Ho\u010devar","year":"2018","journal-title":"OMICS A Journal of Integrative Biology"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0295","doi-asserted-by":"crossref","first-page":"116681","DOI":"10.1016\/j.lfs.2019.116681","article-title":"Perturbed ovarian and uterine glucocorticoid receptor signaling accompanies the balanced regulation of mitochondrial function and NF\u03baB-mediated inflammation under conditions of hyperandrogenism and insulin resistance","volume":"232","author":"Hu","year":"2019","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0300","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(00)80555-3","article-title":"Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12","volume":"96","author":"Huse","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/MMBR.69.1.79-100.2005","article-title":"Signaling by target of rapamycin proteins in cell growth control","volume":"69","author":"Inoki","year":"2005","journal-title":"Microbiology and Molecular Biology Reviews: MMBR"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0310","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/1471-2407-9-442","article-title":"ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells","volume":"9","author":"Jantaratnotai","year":"2009","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0315","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1593\/neo.07929","article-title":"FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-\u03baB signaling pathway","volume":"10","author":"Jiang","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0320","doi-asserted-by":"crossref","DOI":"10.1007\/s00109-014-1173-y","article-title":"Graft microvascular disease in solid organ transplantation","author":"Jiang","year":"2014","journal-title":"Journal of Molecular Medicine. Springer Verlag"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0325","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000123041","article-title":"FKBP family proteins: Immunophilins with versatile biological functions","volume":"16","author":"Kang","year":"2008","journal-title":"Neuro-Signals"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107623_bb0330","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/eji.201847699","article-title":"FKBP51 modulates steroid sensitivity and NF\u03baB signalling: A novel anti-inflammatory drug target","volume":"48","author":"K\u00e4stle","year":"2018","journal-title":"European Journal of Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107623_bb0335","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.1103040","article-title":"Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs","volume":"188","author":"Kim","year":"2012","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0340","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3389\/fphar.2018.01425","article-title":"FKBP ligands\u2014Where we are and where to go?","volume":"9","author":"Kolos","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107623_bb0345","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1073\/pnas.0438007100","article-title":"The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis","volume":"100","author":"Krummrei","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0350","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1874467208666150519113833","article-title":"Regulation of NF-\u03baB signalling cascade by immunophilins","volume":"9","author":"Lagadari","year":"2015","journal-title":"Current Molecular Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107623_bb0355","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.molonc.2016.05.002","article-title":"Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity","volume":"10","author":"Lagadari","year":"2016","journal-title":"Molecular Oncology"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2012.03.017","article-title":"MTOR signaling in growth control and disease","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107623_bb0365","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1210\/en.2010-0225","article-title":"Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice","volume":"151","author":"Lee","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0370","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","article-title":"TGF-\u03b2: A master of all T cell trades","volume":"134","author":"Li","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: One drug, many effects","author":"Li","year":"2014","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0380","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0385","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107623_bb0390","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.15252\/embj.201695669","article-title":"USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling","volume":"36","author":"Luo","year":"2017","journal-title":"The EMBO Journal"},{"issue":"38","key":"10.1016\/j.pharmthera.2020.107623_bb0395","doi-asserted-by":"crossref","first-page":"25963","DOI":"10.1074\/jbc.M802356200","article-title":"The switch I region of Rheb is critical for its interaction with FKBP38","volume":"283","author":"Ma","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107623_bb0400","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2012.12.029","article-title":"FK506 binding proteins: Cellular regulators of intracellular Ca2+ signalling","volume":"700","author":"MacMillan","year":"2013","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0405","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1074-7613(00)80166-1","article-title":"Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52","volume":"12","author":"Mamane","year":"2000","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.pharmthera.2020.107623_bb0410","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.7150\/thno.35561","article-title":"FKBP4 connects mTORC2 and PI3K to activate the PDK1\/Akt-dependent cell proliferation signaling in breast cancer","volume":"9","author":"Mang\u00e9","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: Navigating downstream","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107623_bb0420","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1128\/MCB.00678-12","article-title":"Large FK506-binding proteins shape the pharmacology of rapamycin","volume":"33","author":"M\u00e4rz","year":"2013","journal-title":"Molecular and Cellular Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107623_bb0425","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.biopsych.2018.01.021","article-title":"Understanding the molecular mechanisms underpinning gene by environment interactions in psychiatric disorders: The FKBP5 model","volume":"83","author":"Matosin","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0430","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1874467208666150519115729","article-title":"The role of peptidyl prolyl isomerases in aging and vascular diseases","volume":"9","author":"McClements","year":"2015","journal-title":"Current Molecular Pharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107623_bb0435","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1210\/en.2008-0168","article-title":"A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling","volume":"149","author":"McKeen","year":"2008","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054208","article-title":"Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107","volume":"8","author":"Mei","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0445","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/CS20171457","article-title":"Rapamycin activates TGF receptor independently of its ligand: Implications for endothelial dysfunction","volume":"132","author":"Miyakawa","year":"2018","journal-title":"Clinical Science"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0450","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","author":"Naesens","year":"2009","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"5704","key":"10.1016\/j.pharmthera.2020.107623_bb0455","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0460","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2014.11.001","article-title":"Targeting the TGF\u03b2 pathway for cancer therapy","volume":"147","author":"Neuzillet","year":"2015","journal-title":"Pharmacology & Therapeutics"},{"issue":"17","key":"10.1016\/j.pharmthera.2020.107623_bb0465","doi-asserted-by":"crossref","first-page":"R741","DOI":"10.1016\/j.cub.2012.07.024","article-title":"Ageing as a risk factor for disease","volume":"22","author":"Niccoli","year":"2012","journal-title":"Current Biology: CB"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0470","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/me.2009-0443","article-title":"Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions","volume":"24","author":"Paakinaho","year":"2010","journal-title":"Molecular Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0475","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccr.2009.07.016","article-title":"FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt","volume":"16","author":"Pei","year":"2009","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0480","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pharmtox.37.1.297","article-title":"The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via map kinase","volume":"37","author":"Pratt","year":"1997","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107623_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013279","article-title":"Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids","volume":"5","author":"Presman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2011.08.005","article-title":"The central role of calcium in the effects of cytokines on beta-cell function: Implications for type 1 and type 2 diabetes","author":"Ramadan","year":"2011","journal-title":"Cell Calcium Elsevier Ltd"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0495","doi-asserted-by":"crossref","first-page":"126","DOI":"10.17980\/2017.126","article-title":"Peptidyl-prolyl isomerase (PPIase): An emerging area in tumor biology","volume":"3","author":"Ranjan Nath","year":"2017","journal-title":"Cancer Research Frontiers"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0500","first-page":"31","article-title":"Steroid receptor-associated immunophilins: A gateway to steroid signalling","volume":"36","author":"Ratajczak","year":"2015","journal-title":"The Clinical Biochemist. Reviews\/Australian Association of Clinical Biochemists"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0505","first-page":"663","article-title":"Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the Immunophilin FKBP51 1","volume":"84","author":"Reynolds","year":"1999","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107623_bb0510","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/emboj\/cdg108","article-title":"The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo","volume":"22","author":"Riggs","year":"2003","journal-title":"The EMBO Journal"},{"issue":"24","key":"10.1016\/j.pharmthera.2020.107623_bb0515","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1128\/MCB.00985-07","article-title":"Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling","volume":"27","author":"Riggs","year":"2007","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/srep27915","article-title":"Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling","volume":"6","author":"Rodrigues-Diez","year":"2016","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2001-1326-3-1","article-title":"FKBP51 increases the tumour-promoter potential of TGF-beta","volume":"3","author":"Romano","year":"2014","journal-title":"Clinical and Translational Medicine"},{"issue":"14","key":"10.1016\/j.pharmthera.2020.107623_bb0530","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1093\/nar\/gkv615","article-title":"FKBP51 employs both scaffold and isomerase functions to promote NF-\u03baB activation in melanoma","volume":"43","author":"Romano","year":"2015","journal-title":"Nucleic Acids Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107623_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107241","article-title":"Age-associated epigenetic upregulation of the FKBP5 gene selectively impairs stress resiliency","volume":"9","author":"Sabbagh","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0540","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti- and pro-inflammatory roles of TGF-\u03b2, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Current Opinion in Pharmacology"},{"issue":"27","key":"10.1016\/j.pharmthera.2020.107623_bb0545","doi-asserted-by":"crossref","first-page":"27845","DOI":"10.1074\/jbc.C400118200","article-title":"A novel role for the immunophilin FKBP52 in copper transport","volume":"279","author":"Sanokawa-Akakura","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0550","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Molecular Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0555","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/gcen.2001.7696","article-title":"Overexpression of the FK506-binding Immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World Primates","volume":"124","author":"Scammell","year":"2001","journal-title":"General and Comparative Endocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0560","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/acel.12313","article-title":"Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins","volume":"14","author":"Schreiber","year":"2015","journal-title":"Aging Cell"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107623_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011717","article-title":"Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors","volume":"5","author":"Sch\u00fclke","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0570","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-08-1845","article-title":"IRF4: Immunity. malignancy! therapy?","author":"Shaffer","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107623_bb0575","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1093\/nar\/gkz108","article-title":"LncRNA PCAT1 activates AKT and NF-B signaling in castration-resistant prostate cancer by regulating the PHLPP\/FKBP51\/IKK complex","volume":"47","author":"Shang","year":"2019","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0580","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: The mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Shimobayashi","year":"2014","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0585","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biocel.2014.03.007","article-title":"Mitochondria: FKBP38 and mitochondrial degradation","volume":"51","author":"Shirane-Kitsuji","year":"2014","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"6397","key":"10.1016\/j.pharmthera.2020.107623_bb0590","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-\u03b21 gene results in multifocal inflammatory disease","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0595","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.coph.2011.03.012","article-title":"FKBP family proteins as promising new biomarkers for cancer","volume":"11","author":"Solassol","year":"2011","journal-title":"Current Opinion in Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107623_bb0600","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1172\/JCI65592","article-title":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension","volume":"123","author":"Spiekerkoetter","year":"2013","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0605","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.coph.2011.04.012","article-title":"FKBP51-a selective modulator of glucocorticoid and androgen sensitivity","volume":"11","author":"Stechschulte","year":"2011","journal-title":"Current Opinion in Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107623_bb0610","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1074\/jbc.M211261200","article-title":"Evidence that peroxisome proliferator-activated receptor \u03b1 is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2","volume":"278","author":"Sumanasekera","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107623_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065284","article-title":"Association of Eosinophilic Inflammation with FKBP51 expression in sputum cells in asthma","volume":"8","author":"Tajiri","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0620","series-title":"Transplantation","article-title":"Incidence and prevalence of renal transplantation throughout transplantation","author":"Thomas","year":"2014"},{"issue":"23","key":"10.1016\/j.pharmthera.2020.107623_bb0625","first-page":"5357","article-title":"Dynamic mitochondrial-nuclear redistribution of the immunophilin FKBP51 is regulated by the PKA signaling pathway to control gene expression during adipocyte differentiation","volume":"126","author":"Toneatto","year":"2013","journal-title":"Journal of Cell Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0630","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1874467208666150519113541","article-title":"FK506-binding proteins and their diverse functions","volume":"9","author":"Tong","year":"2015","journal-title":"Current Molecular Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107623_bb0635","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/1078-0432.CCR-10-2241","article-title":"FKBPL and peptide derivatives: Novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism","volume":"17","author":"Valentine","year":"2011","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0640","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1601515","article-title":"Akt signaling pathway in macrophage activation and M1\/M2 polarization","volume":"198","author":"Vergadi","year":"2017","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0645","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2002-020354","article-title":"Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency, and bioavailability","volume":"88","author":"Vermeer","year":"2003","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0650","article-title":"Calcium signaling in immune cells","author":"Vig","year":"2009","journal-title":"Nature Immunology"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107623_bb0655","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.4049\/jimmunol.1103143","article-title":"Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells","volume":"188","author":"Waickman","year":"2012","journal-title":"The Journal of Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0660","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1677\/jme.0.0280177","article-title":"Identification of genes differentially regulated by glucocorticoids and progestins using a Cre\/loxP-mediated retroviral promoter-trapping strategy","volume":"28","author":"Wan","year":"2002","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2011.03.008","article-title":"FKBP51 regulation of AKT\/protein kinase B phosphorylation","author":"Wang","year":"2011","journal-title":"Current Opinion in Pharmacology Elsevier Ltd"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.01010","article-title":"Weighted gene co-expression network analysis identifies FKBP11 as a key regulator in acute aortic dissection through a NF-kB dependent pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Frontiers in Physiology"},{"issue":"50","key":"10.1016\/j.pharmthera.2020.107623_bb0675","doi-asserted-by":"crossref","first-page":"14637","DOI":"10.1021\/bi020574b","article-title":"Proline Cis\u2212trans isomerization and protein folding \u2020","volume":"41","author":"Wedemeyer","year":"2002","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0680","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107623_bb0685","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/sj.bjp.0703223","article-title":"Augmentation of SR Ca2+ release by rapamycin and FK506 causes K+-channel activation and membrane hyperpolarization in bladder smooth muscle","volume":"129","author":"Weidelt","year":"2000","journal-title":"British Journal of Pharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107623_bb0690","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jsbmb.2006.03.004","article-title":"Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51","volume":"100","author":"Westberry","year":"2006","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2020.107623_bb0695","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jsbmb.2006.03.004","article-title":"Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51","volume":"100","author":"Westberry","year":"2006","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0700","first-page":"5","article-title":"Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity","author":"Willmann","year":"2014","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107623_bb0705","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1021\/acs.jproteome.5b01004","article-title":"Expanding the Interactome of the noncanonical NF-\u03baB signaling pathway","volume":"15","author":"Willmann","year":"2016","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0710","article-title":"Psychological stress, inflammation, and coronary heart disease","volume":"1","author":"Wirtz","year":"2017","journal-title":"Current Cardiology Reports Current Medicine Group LLC"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107623_bb0715","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1074\/jbc.M407498200","article-title":"FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells","volume":"280","author":"Wochnik","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0720","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03609-x","article-title":"The orphan GPR50 receptor promotes constitutive TGF\u03b2 receptor signaling and protects against cancer development","volume":"9","author":"Wojciech","year":"2018","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0725","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","article-title":"NF-\u03baB-inducing kinase regulates the processing of NF-\u03baB2 p100","volume":"7","author":"Xiao","year":"2001","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0730","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-2187-8-7","article-title":"TRAF molecules in cell signaling and in human diseases","volume":"8","author":"Xie","year":"2013","journal-title":"Journal of Molecular Signaling"},{"issue":"22","key":"10.1016\/j.pharmthera.2020.107623_bb0735","doi-asserted-by":"crossref","first-page":"15315","DOI":"10.1074\/jbc.274.22.15315","article-title":"Three amino acid residues determine selective binding of FK506-binding protein 12.6 to the cardiac ryanodine receptor","volume":"274","author":"Xin","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107623_bb0740","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/ATVBAHA.114.304539","article-title":"FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis","volume":"35","author":"Yakkundi","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0745","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1677\/jme.1.01966","article-title":"FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor","volume":"36","author":"Yamaguchi","year":"2006","journal-title":"Journal of Molecular Endocrinology"},{"issue":"25","key":"10.1016\/j.pharmthera.2020.107623_bb0750","doi-asserted-by":"crossref","first-page":"15187","DOI":"10.1074\/jbc.270.25.15187","article-title":"Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity","volume":"270","author":"Yang","year":"1995","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107623_bb0755","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1074\/jbc.M117.812289","article-title":"Toll-like receptor 4 \u2013induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca2 leakage promote cardiac contractile dysfunction in sepsis","volume":"293","author":"Yang","year":"2018","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107623_bb0760","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.277","article-title":"K+ regulates Ca2+ to drive inflammasome signaling: Dynamic visualization of ion flux in live cells","volume":"6","author":"Yaron","year":"2015","journal-title":"Cell Death & Disease"},{"issue":"34","key":"10.1016\/j.pharmthera.2020.107623_bb0765","doi-asserted-by":"crossref","first-page":"29568","DOI":"10.1074\/jbc.M111.262816","article-title":"Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect","volume":"286","author":"Yoon","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107623_bb0770","series-title":"Molecular psychiatry","article-title":"Epigenetic programming by stress and glucocorticoids along the human lifespan","author":"Zannas","year":"2017"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0775","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-015-0828-5","article-title":"Lifetime stress accelerates epigenetic aging in an urban, African American cohort: Relevance of glucocorticoid signaling","volume":"16","author":"Zannas","year":"2015","journal-title":"Genome Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107623_bb0780","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/npp.2015.235","article-title":"Gene\u2013stress\u2013epigenetic regulation of FKBP5: Clinical and translational implications","volume":"41","author":"Zannas","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"23","key":"10.1016\/j.pharmthera.2020.107623_bb0790","doi-asserted-by":"crossref","first-page":"11370","DOI":"10.1073\/pnas.1816847116","article-title":"Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-\u03baB-driven inflammation and cardiovascular risk","volume":"116","author":"Zannas","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107623_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/biom9020052","article-title":"Biological actions of the Hsp90-binding immunophilins FKBP51 and FKBP52","volume":"9","author":"Zgajnar","year":"2019","journal-title":"Biomolecules"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:06:15Z","timestamp":1759010775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820301534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":157,"alternative-id":["S0163725820301534"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107623","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107623"}}